Cytokine modulation by PX differently affects specific acute phase proteins during sepsis in rats

Autor: Benoît Ruot, F. Rambourdin, L. Voisin, Christiane Obled, Cécile Rallière, Michel Dalle, Denis Breuille
Přispěvatelé: Unité de nutrition et métabolisme protéique, Institut National de la Recherche Agronomique (INRA), Université Blaise Pascal - Clermont-Ferrand 2 (UBP), Nestlé, Nestlé S.A.
Jazyk: angličtina
Rok vydání: 1998
Předmět:
Male
interleukine
infection expérimentale
Physiology
medicine.medical_treatment
régulation physiologique
rattus rattus
Pentoxifylline
Rats
Sprague-Dawley

0302 clinical medicine
cytokine
Escherichia coli Infections
bactérie
0303 health sciences
biology
Acute-phase protein
Free Radical Scavengers
3. Good health
Cytokine
030220 oncology & carcinogenesis
Tumor necrosis factor alpha
medicine.symptom
escherichia coli
arn messager
medicine.drug
medicine.medical_specialty
Médecine humaine et pathologie
Inflammation
Sepsis
03 medical and health sciences
In vivo
Physiology (medical)
Internal medicine
medicine
Animals
albumine
Interleukin 6
030304 developmental biology
glycoprotéine
Interleukin-6
Tumor Necrosis Factor-alpha
medicine.disease
macroglobuline
Rats
nécrose
Endocrinology
biology.protein
RAT
Human health and pathology
fibrinogène
expérimentation in vivo
[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology
Acute-Phase Proteins
Interleukin-1
Zdroj: AJP-Regulatory, Integrative and Comparative Physiology
AJP-Regulatory, Integrative and Comparative Physiology, American Physiological Society, 1998, 275 (5), pp.R1412-R1419
American Journal of Physiology. Regulatory, Integrative and Comparative Physiology 5 (275), R1412-R1419. (1998)
ISSN: 0363-6119
1522-1490
Popis: To explore the regulation of the acute phase response in vivo, the effects of pentoxifylline (PX) treatment (100 mg/kg ip 1 h before infection) were investigated in infected and pair-fed rats 2 and 6 days after an intravenous injection of live bacteria ( Escherichia coli). PX treatment prevented the increase in plasma tumor necrosis factor (TNF)-α (peak 1.5 h after the infection) and resulted in an 84 and 61% inhibition of plasma interleukin (IL)-1β and IL-6, respectively (peaks at 3 h). Plasma corticosterone kinetics were not modified by the treatment. Infection increased α1-acid glycoprotein (AGP), α2-macroglobulin (A2M), and fibrinogen plasma concentrations and decreased albumin levels. PX significantly reduced AGP plasma concentration as early as day 2 in infected animals but reduced A2M and fibrinogen plasma levels only at day 6. The treatment had no effect on the albumin plasma concentration. Hepatic AGP and fibrinogen mRNA levels increased in infected rats, whereas those of A2M were unchanged and those of albumin were decreased. Two days after infection, AGP and fibrinogen mRNA levels were reduced in treated infected animals. PX was ineffective in modifying those of A2M and albumin. These data demonstrate, in vivo, that different acute phase proteins are individually regulated in sepsis. The in vivo effects of PX treatment support the hypothesis that TNF-α plays an important role in the regulation of AGP production, whereas other factors seem to be involved in the regulation of A2M, fibrinogen, and albumin expression.
Databáze: OpenAIRE